The independent source for health policy research, polling, and news.
Juliette Cubanski
Dec 2, 2024
It’s quite likely that one of these popular anti-obesity medications will be selected for negotiation in the next round of Medicare’s relatively new drug price negotiation program. … more
Drew Altman
Oct 30, 2024
This election is a choice in health between aggressive incrementalism and a sharp right-hand turn in federal policy and spending, but ... no one should doubt the capacity of our system and institutions to thwart dramatic change in any direction. … more